Skip to main content
Erschienen in: Pediatric Cardiology 4/2012

01.04.2012 | Original Article

Risk Factors Associated With Morbidity and Mortality After Pulmonary Valve Replacement in Adult Patients With Previously Corrected Tetralogy of Fallot

verfasst von: Ashish Jain, Matthew Oster, Pat Kilgo, Joanna Grudziak, Maan Jokhadar, Wendy Book, Brian E. Kogon

Erschienen in: Pediatric Cardiology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Patients with palliated tetralogy of Fallot (TOF) often require pulmonary valve replacement in adulthood, yet the data regarding their outcomes are scarce. This study aimed to identify risk factors associated with postoperative complications in these patients and to establish long-term survival data for this patient group. A retrospective cohort study investigated 153 consecutive patients with a history of TOF repair who underwent pulmonary valve replacement at a single large academic center between March 1996 and March 2010. In part 1 of the study, logistic models were constructed to assess demographic, medical, and surgical risk factors for operative mortality; occurrence of a major adverse event (stroke, renal failure, prolonged ventilation, deep sternal infection, reoperation, or operative mortality); and prolonged hospital stay (>7 days). Risk factors with a p value less than 0.10 by univariate analysis were included in the subsequent multivariate analysis. In part 2 of the study, long-term, all-cause mortality was determined by construction of a Kaplan–Meier curve for the cohort. Seven patients died (4.5%). Significant risk factors for mortality in the multivariable analysis included age older than 40 years (odds ratio (OR) 9.89) and concomitant surgery (OR 6.65). A major adverse event occurred for 22 patients (14.4%). The only significant risk factor in the multivariable analysis for an adverse event was concomitant surgery (OR 6.42). The hospital stay was longer than 7 days for 31 patients (20.3%). The significant risk factors for a prolonged hospital stay included the presence of preoperative arrhythmias (OR 4.17), New York Heart Association class 3 (OR 4.35), and again, concomitant surgery (OR 4.2). Among the 146 hospital survivors, only 5 patients died in the intervening period. The predicted survival rates were 98.5% at 1 year, 96.7% at 5 years, and 93.5% at 10 years. Pulmonary valve replacement in adults with palliated TOF is a safe procedure with excellent long-term survival, but there remain important risk factors for postoperative mortality, prolonged hospital stay, and major adverse events. Awareness and modification of important risk factors may help to improve outcomes.
Literatur
2.
Zurück zum Zitat Berdat PA, Immer F, Pfammatter JP, Carrel T (2004) Reoperations in adults with congenital heart disease: analysis of early outcome. Int J Cardiol 93:239–245PubMedCrossRef Berdat PA, Immer F, Pfammatter JP, Carrel T (2004) Reoperations in adults with congenital heart disease: analysis of early outcome. Int J Cardiol 93:239–245PubMedCrossRef
3.
Zurück zum Zitat Bouzas B, Kilner PJ, Gatzoulis MA (2005) Pulmonary regurgitation: not a benign lesion. Eur Heart J 26:433–439PubMedCrossRef Bouzas B, Kilner PJ, Gatzoulis MA (2005) Pulmonary regurgitation: not a benign lesion. Eur Heart J 26:433–439PubMedCrossRef
4.
Zurück zum Zitat Coskun KO, Popov AF, Tirilomis T, Schmitto JD, Coskun ST, Hinz J et al (2010) Aortic valve surgery in congenital heart disease: a single-center experience. Artif Organs 34:E85–E90PubMedCrossRef Coskun KO, Popov AF, Tirilomis T, Schmitto JD, Coskun ST, Hinz J et al (2010) Aortic valve surgery in congenital heart disease: a single-center experience. Artif Organs 34:E85–E90PubMedCrossRef
5.
Zurück zum Zitat De Cocker J, Messaoudi N, Stockman BA, Bossaert LL, Rodrigus IE (2011) Preoperative prediction of intensive care unit stay following cardiac surgery. Eur J Cardiothorac Surg 39(1):60–67PubMedCrossRef De Cocker J, Messaoudi N, Stockman BA, Bossaert LL, Rodrigus IE (2011) Preoperative prediction of intensive care unit stay following cardiac surgery. Eur J Cardiothorac Surg 39(1):60–67PubMedCrossRef
6.
Zurück zum Zitat Dearani JA, Mavroudis C, Quintessenza J, Deal BJ, Backer CL, Fitzgerald P et al (2009) Surgical advances in the treatment of adults with congenital heart disease. Curr Opin Pediatr 21:565–572PubMedCrossRef Dearani JA, Mavroudis C, Quintessenza J, Deal BJ, Backer CL, Fitzgerald P et al (2009) Surgical advances in the treatment of adults with congenital heart disease. Curr Opin Pediatr 21:565–572PubMedCrossRef
7.
Zurück zum Zitat Dore A, Glancy DL, Stone S, Menashe VD, Somerville J (1997) Cardiac surgery for grown-up congenital heart patients: survey of 307 consecutive operations from 1991 to 1994. Am J Cardiol 80:906–913PubMedCrossRef Dore A, Glancy DL, Stone S, Menashe VD, Somerville J (1997) Cardiac surgery for grown-up congenital heart patients: survey of 307 consecutive operations from 1991 to 1994. Am J Cardiol 80:906–913PubMedCrossRef
8.
Zurück zum Zitat Dos L, Dadashev A, Tanous D, Ferreira-González IJ, Haberer K, Siu SC, Van Arsdell GS, Oechslin EN, Williams WG, Silversides CK (2009) Pulmonary valve replacement in repaired tetralogy of Fallot: determinants of early postoperative adverse outcomes. J Thorac Cardiovasc Surg 138:553–559PubMedCrossRef Dos L, Dadashev A, Tanous D, Ferreira-González IJ, Haberer K, Siu SC, Van Arsdell GS, Oechslin EN, Williams WG, Silversides CK (2009) Pulmonary valve replacement in repaired tetralogy of Fallot: determinants of early postoperative adverse outcomes. J Thorac Cardiovasc Surg 138:553–559PubMedCrossRef
9.
Zurück zum Zitat Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilen U et al (2005) The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5-year follow-up period. The Euro heart survey on adult congenital heart disease. Eur Heart J 26:2325–2333PubMedCrossRef Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilen U et al (2005) The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5-year follow-up period. The Euro heart survey on adult congenital heart disease. Eur Heart J 26:2325–2333PubMedCrossRef
10.
Zurück zum Zitat Frigiola A, Redington AN, Cullen S, Vogel M (2004) Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation 110(11 Suppl 1):II153–II157PubMed Frigiola A, Redington AN, Cullen S, Vogel M (2004) Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation 110(11 Suppl 1):II153–II157PubMed
11.
Zurück zum Zitat Gatzoulis MA, Elliott JT, Guru V, Siu SC, Warsi MA, Webb GD et al (2000) Right and left ventricular systolic function late after repair of tetralogy of Fallot. Am J Cardiol 86:1352–1357PubMedCrossRef Gatzoulis MA, Elliott JT, Guru V, Siu SC, Warsi MA, Webb GD et al (2000) Right and left ventricular systolic function late after repair of tetralogy of Fallot. Am J Cardiol 86:1352–1357PubMedCrossRef
12.
Zurück zum Zitat Giamberti A, Chessa M, Abella R, Butera G, Carlucci C, Nuri H et al (2009) Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg 88:1284–1289PubMedCrossRef Giamberti A, Chessa M, Abella R, Butera G, Carlucci C, Nuri H et al (2009) Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg 88:1284–1289PubMedCrossRef
13.
Zurück zum Zitat Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, Walsh E (2009) Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation 119:445–451PubMedCrossRef Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, Walsh E (2009) Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation 119:445–451PubMedCrossRef
14.
Zurück zum Zitat Ivanov J, Borger MA, Rao V, David TE (2006) The Toronto risk score for adverse events following cardiac surgery. Can J Cardiol 22:221–227PubMedCrossRef Ivanov J, Borger MA, Rao V, David TE (2006) The Toronto risk score for adverse events following cardiac surgery. Can J Cardiol 22:221–227PubMedCrossRef
15.
Zurück zum Zitat Klieverik LM, Bekkers JA, Roos JW, Eijkemans MJ, Raap GB, Bogers AJ et al (2008) Autograft or allograft aortic valve replacement in young adult patients with congenital aortic valve disease. Eur Heart J 29:1446–1453PubMedCrossRef Klieverik LM, Bekkers JA, Roos JW, Eijkemans MJ, Raap GB, Bogers AJ et al (2008) Autograft or allograft aortic valve replacement in young adult patients with congenital aortic valve disease. Eur Heart J 29:1446–1453PubMedCrossRef
16.
Zurück zum Zitat Luciani GB, Viscardi F, Pilati M, Barozzi L, Faggian G, Mazzucco A (2008) Operative risk and outcome of surgery in adults with congenital valve disease. ASAIO J 54:458–462PubMedCrossRef Luciani GB, Viscardi F, Pilati M, Barozzi L, Faggian G, Mazzucco A (2008) Operative risk and outcome of surgery in adults with congenital valve disease. ASAIO J 54:458–462PubMedCrossRef
17.
Zurück zum Zitat Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM et al (1993) Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 329:593–599PubMedCrossRef Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM et al (1993) Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 329:593–599PubMedCrossRef
18.
Zurück zum Zitat Oechslin EN, Harrison DA, Harris L, Downar E, Webb GD, Siu SS et al (1999) Reoperation in adults with repair of tetralogy of Fallot: indications and outcomes. J Thorac Cardiovasc Surg 118:245–251PubMedCrossRef Oechslin EN, Harrison DA, Harris L, Downar E, Webb GD, Siu SS et al (1999) Reoperation in adults with repair of tetralogy of Fallot: indications and outcomes. J Thorac Cardiovasc Surg 118:245–251PubMedCrossRef
19.
Zurück zum Zitat Opotowsky AR, Siddiqi OK, Webb GD (2009) Trends in hospitalizations for adults with congenital heart disease in the US. J Am Coll Cardiol 54(5):460–467PubMedCrossRef Opotowsky AR, Siddiqi OK, Webb GD (2009) Trends in hospitalizations for adults with congenital heart disease in the US. J Am Coll Cardiol 54(5):460–467PubMedCrossRef
20.
Zurück zum Zitat Parsonnet V, Dean D, Bernstein AD (1989) A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79(6 Pt 2):I3–I12PubMed Parsonnet V, Dean D, Bernstein AD (1989) A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79(6 Pt 2):I3–I12PubMed
22.
Zurück zum Zitat Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD (2000) Pulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late? J Am Coll Cardiol 36:1670–1675PubMedCrossRef Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD (2000) Pulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late? J Am Coll Cardiol 36:1670–1675PubMedCrossRef
23.
Zurück zum Zitat Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J et al (2001) Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 103:2489–2494PubMed Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J et al (2001) Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 103:2489–2494PubMed
24.
Zurück zum Zitat Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G (2005) Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 95:779–782PubMedCrossRef Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G (2005) Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 95:779–782PubMedCrossRef
25.
Zurück zum Zitat Trojnarska O, Grajek S, Katarzynski S, Kramer L (2009) Predictors of mortality in adult patients with congenital heart disease. Cardiol J 16:341–347PubMed Trojnarska O, Grajek S, Katarzynski S, Kramer L (2009) Predictors of mortality in adult patients with congenital heart disease. Cardiol J 16:341–347PubMed
26.
Zurück zum Zitat Vida VL, Berggren H, Brawn WJ, Daenen W, Di Carlo D, Di Donato R et al (2007) Risk of surgery for congenital heart disease in the adult: a multicentered European study. Ann Thorac Surg 83:161–168PubMedCrossRef Vida VL, Berggren H, Brawn WJ, Daenen W, Di Carlo D, Di Donato R et al (2007) Risk of surgery for congenital heart disease in the adult: a multicentered European study. Ann Thorac Surg 83:161–168PubMedCrossRef
27.
Zurück zum Zitat Yemets IM, Williams WG, Webb GD, Harrison DA, McLaughlin PR, Trusler GA et al (1997) Pulmonary valve replacement late after repair of tetralogy of Fallot. Ann Thorac Surg 64:526–530PubMedCrossRef Yemets IM, Williams WG, Webb GD, Harrison DA, McLaughlin PR, Trusler GA et al (1997) Pulmonary valve replacement late after repair of tetralogy of Fallot. Ann Thorac Surg 64:526–530PubMedCrossRef
Metadaten
Titel
Risk Factors Associated With Morbidity and Mortality After Pulmonary Valve Replacement in Adult Patients With Previously Corrected Tetralogy of Fallot
verfasst von
Ashish Jain
Matthew Oster
Pat Kilgo
Joanna Grudziak
Maan Jokhadar
Wendy Book
Brian E. Kogon
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 4/2012
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0185-z

Weitere Artikel der Ausgabe 4/2012

Pediatric Cardiology 4/2012 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.